Shares of Biomerica Inc. (BMRA) are surging over 28% in pre-market today, after the company announced that it has received a CE mark and launched a new high-volume production version of its COVID-19 IgG/IgM Rapid Test (a finger prick blood test with results in 10 minutes, that can be performed by trained professionals anywhere) being sold in countries outside the US.
This new high-volume version of the disposable serology test allows the company to ramp up production utilizing a proprietary card system that eliminates most plastic. This version also has the benefit of being environmentally friendly, the company said.
Biomerica also announced it is now filling and has shipped commercial orders of its previously announced version of the product to company distributors who are supplying customers that include NATO, and government agencies in Germany, Switzerland and the Netherlands.
The stock has been trading in the range of $2.05 - $23.39 for the past one year, and closed Wednesday's trade at $6.55, down 28 cents or 4.10%. BMRA is currently trading at $8.44, up $1.89 or 28.85% in the pre-market session.
For comments and feedback contact: editorial@rttnews.com
Business News
April 17, 2026 15:29 ET The ongoing conflict in the Middle East continues to raise concerns for policymakers who worry about the impact of the supply shock and high energy prices on the real economy. Producer price data and various survey results on the housing market were the main news from the U.S. this week. In Europe, industrial production data for the euro area gained attention. GDP figures out of China and the policy move by the Singapore central bank were in focus in Asia.